SEC Filing Summary: Colfax Corporation (CFX)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Colfax Corporation on February 23, 2021, covering events occurring on February 22, 2021. The registrant is incorporated in Delaware and trades on the New York Stock Exchange under the symbols CFX (Common Stock) and CFXA (5.75% Tangible Equity Units).
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The Board of Directors appointed Philip Okala, Chief Operating Officer of the University of Pennsylvania Health System, as a new director. This appointment increased the Board size from ten to eleven members. Mr. Okala was determined to be an independent director with no material relationships to the Company.
Outlook, Risks, and Management Commentary
- Committee Assignment: Mr. Okala is expected to be named to the Compensation Committee.
- Compensation: Mr. Okala will participate in the standard director compensation package, with an initial equity grant pro-rated for the remainder of the year.
- Agreements: A standard indemnification agreement was executed in connection with the appointment.
- Risks: No new risks or contingencies were disclosed in this filing.
Key Facts for Investor Verification
- Verify the independence status of the newly appointed director, Philip Okala.
- Confirm the pro-rated equity grant details in the next proxy statement or equity filing.
- Note that this filing contains no financial results; refer to the most recent 10-Q or 10-K for financial metrics.
- Review the attached press release (Exhibit 99.1) for additional context on the appointment.